Your browser doesn't support javascript.
loading
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Muller, Yannick D; Ghaleb, Nseir; Rotman, Samuel; Vionnet, Julien; Halfon, Matthieu; Catana, Emmanuelle; Golshayan, Déla; Venetz, Jean-Pierre; Aubert, Vincent; Pascual, Manuel.
Afiliação
  • Muller YD; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Ghaleb N; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Rotman S; Service of Clinical Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Vionnet J; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Halfon M; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Catana E; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Golshayan D; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Venetz JP; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Aubert V; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Pascual M; Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Transpl Int ; 31(4): 451-455, 2018 04.
Article em En | MEDLINE | ID: mdl-29328536

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Rituximab / Rejeição de Enxerto / Fatores Imunológicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Rituximab / Rejeição de Enxerto / Fatores Imunológicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article